New research points to a possible link between GLP-1 medications and changes in nails, and doctors weigh in on what so-called Ozempic nails could mean.
Recap by typeshit. Full story at Women's Health on MSN.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Exercise advice aimed at people on GLP-1 medication, shared without further detail on the specific workouts recommended.
A comparison of how the investigational drug retatrutide stacks up on weight loss against existing obesity treatments.
Loading…